Paul Bisaro

Companies

• Myriad GeneticsBoard member Nov 1, 2022 to now¹
• Keenova Therapeutics plcBoard member Jun 24, 2022 to now²
• ZoetisBoard member May 1, 2015 to now³
• TherapeuticsMD, Inc.Board member Mar 26, 2020 to Oct 3, 2022⁴
• Amneal Pharmaceuticals, Inc.Chair Mar 5, 2019 to May 9, 2019⁵
• Amneal Pharmaceuticals, Inc.Board member May 8, 2018 to May 8, 2018⁶
• Allergan plcBoard member Feb 6, 2017 to May 4, 2018⁷
• Zimmer Biomet HoldingsBoard member Dec 16, 2013 to Apr 4, 2017⁸
• Allergan plcChair Oct 3, 2013 to Feb 3, 2017⁹
• Allergan plcChief executive officer Oct 3, 2013 to May 13, 2014⁹
• ActavisBoard member Sep 4, 2007 to Oct 2, 2013¹⁰
• ActavisChief executive officer Sep 4, 2007 to Oct 2, 2013¹⁰
• ActavisPresident Sep 4, 2007 to Oct 2, 2013¹⁰

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Zoetis ZTS27,862 shares¹¹$2.2M at $79.28May 13, 2026
• Myriad Genetics MYGN157,142 shares¹²$683.6K at $4.35Jun 4, 2026
• TTherapeuticsMD, Inc. TXMD5,922 shares¹³$11.4K at $1.93Aug 18, 2022
• KTKeenova Therapeutics plc6,244 shares¹⁴Jun 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 4, 2026Granted 59,701 shares of Myriad Genetics¹²
• Jun 2, 2026Shares withheld for tax 619 shares of Keenova Therapeutics plc¹⁴
• Jun 2, 2026Exercised options 2,685 shares of Keenova Therapeutics plc¹⁴
• May 14, 2026Bought 7,500 shares at $3.69 of Myriad Genetics¹⁵
• May 13, 2026Bought 2,000 shares at $75.88 of Zoetis¹¹
• Feb 19, 2026Exercised options 1,619 shares of Zoetis¹⁶
• Jan 1, 2026Shares withheld for tax 854 shares of Keenova Therapeutics plc¹⁷
• Jan 1, 2026Exercised options 3,014 shares of Keenova Therapeutics plc¹⁷
• Jun 5, 2025Granted 49,796 shares of Myriad Genetics¹⁸
• Feb 8, 2025Exercised options 1,225 shares of Zoetis¹⁹
• Feb 6, 2025Exercised options 1,236 shares of Zoetis²⁰
• Jan 1, 2025Shares withheld for tax 489 shares of Keenova Therapeutics plc²¹
• Jan 1, 2025Exercised options 2,507 shares of Keenova Therapeutics plc²¹
• Jun 6, 2024Granted 15,695 shares of Myriad Genetics²²
• Feb 10, 2024Exercised options 1,463 shares of Zoetis²³
• Feb 8, 2024Exercised options 1,493 shares of Zoetis²⁴
• Nov 14, 2023Returned to company 32,048 shares of Keenova Therapeutics plc²⁵
• Jun 16, 2023Returned to company 39,083 shares of Keenova Therapeutics plc²⁶
• Jun 16, 2023Shares withheld for tax 3,689 shares at $1.28 of Keenova Therapeutics plc²⁶
• Jun 1, 2023Granted 7,575 shares of Myriad Genetics²⁷
• Mar 14, 2023Bought 5,000 shares at $8.47 of Keenova Therapeutics plc²⁸
• Feb 11, 2023Exercised options 1,626 shares of Zoetis²⁹
• Jan 3, 2023Granted 39,083 shares of Keenova Therapeutics plc³⁰
• Oct 31, 2022Granted 16,875 shares of Myriad Genetics³¹
• Aug 18, 2022Exercised options 1,984 shares of TherapeuticsMD, Inc.¹³